Literature DB >> 16882881

Transcriptional alterations in the left ventricle of three hypertensive rat models.

Catherine Cerutti1, Mazen Kurdi, Giampiero Bricca, Wassim Hodroj, Christian Paultre, Jacques Randon, Marie-Paule Gustin.   

Abstract

Left ventricular hypertrophy (LVH) is commonly associated with hypertension and represents an independent cardiovascular risk factor. The aim of this study was to test the hypothesis that the cardiac overload related to hypertension is associated to a specific gene expression pattern independently of genetic background. Gene expression levels were obtained with microarrays for 15,866 transcripts from RNA of left ventricles from 12-wk-old rats of three hypertensive models [spontaneously hypertensive rat (SHR), Lyon hypertensive rat (LH), and heterozygous TGR(mRen2)27 rat] and their respective controls. More than 60% of the detected transcripts displayed significant changes between the three groups of normotensive rats, showing large interstrain variability. Expression data were analyzed with respect to hypertension, LVH, and chromosomal distribution. Only four genes had significantly modified expression in the three hypertensive models among which a single gene, coding for sialyltransferase 7A, was consistently overexpressed. Correlation analysis between expression data and left ventricular mass index (LVMI) over all rats identified a larger set of genes whose expression was continuously related with LVMI, including known genes associated with cardiac remodeling. Positioning the detected transcripts along the chromosomes pointed out high-density regions mostly located within blood pressure and cardiac mass quantitative trait loci. Although our study could not detect a unique reprogramming of cardiac cells involving specific genes at early stage of LVH, it allowed the identification of some genes associated with LVH regardless of genetic background. This study thus provides a set of potentially important genes contained within restricted chromosomal regions involved in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882881     DOI: 10.1152/physiolgenomics.00318.2005

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  15 in total

1.  Cardiac-specific NRAP overexpression causes right ventricular dysfunction in mice.

Authors:  Shajia Lu; Garland L Crawford; Justin Dore; Stasia A Anderson; Daryl Despres; Robert Horowits
Journal:  Exp Cell Res       Date:  2011-01-26       Impact factor: 3.905

2.  Role of SDF-1 and Wnt signaling pathway in the myocardial fibrosis of hypertensive rats.

Authors:  Shuai Shao; Wenwei Cai; Jing Sheng; Lingni Yin
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

3.  Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development.

Authors:  Laurence S David; Esperanza Garcia; Stuart M Cain; Elana Thau; John R Tyson; Terrance P Snutch
Journal:  Channels (Austin)       Date:  2010-09-01       Impact factor: 2.581

4.  Genome-Wide Gene-Potassium Interaction Analyses on Blood Pressure: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity).

Authors:  Changwei Li; Jiang He; Jing Chen; Jinying Zhao; Dongfeng Gu; James E Hixson; Dabeeru C Rao; Cashell E Jaquish; Treva K Rice; Yun Ju Sung; Tanika N Kelly
Journal:  Circ Cardiovasc Genet       Date:  2017-12

5.  LTR: Linear Cross-Platform Integration of Microarray Data.

Authors:  Paul C Boutros
Journal:  Cancer Inform       Date:  2010-08-27

Review 6.  Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential.

Authors:  Kristin Dawson; Mona Aflaki; Stanley Nattel
Journal:  J Physiol       Date:  2012-12-03       Impact factor: 5.182

Review 7.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

8.  Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.

Authors:  Jörg Peters; Torsten Schlüter; Thomas Riegel; Barbara S Peters; Andreas Beineke; Ulrike Maschke; Norbert Hosten; John J Mullins; Rainer Rettig
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

9.  Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection.

Authors:  Betti Giusti; Marina Marini; Luciana Rossi; Ilaria Lapini; Alberto Magi; Andrea Capalbo; Rosa Lapalombella; Simona di Tullio; Michele Samaja; Fabio Esposito; Vittoria Margonato; Maria Boddi; Rosanna Abbate; Arsenio Veicsteinas
Journal:  BMC Genomics       Date:  2009-07-30       Impact factor: 3.969

10.  Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass.

Authors:  Enrico Petretto; Rizwan Sarwar; Ian Grieve; Han Lu; Mande K Kumaran; Phillip J Muckett; Jonathan Mangion; Blanche Schroen; Matthew Benson; Prakash P Punjabi; Sanjay K Prasad; Dudley J Pennell; Chris Kiesewetter; Elena S Tasheva; Lolita M Corpuz; Megan D Webb; Gary W Conrad; Theodore W Kurtz; Vladimir Kren; Judith Fischer; Norbert Hubner; Yigal M Pinto; Michal Pravenec; Timothy J Aitman; Stuart A Cook
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.